Insulin resistance in type I diabetes mellitus: A major role for reduced glucose extraction

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 707-712

  Mäkimattila, Sari ^a   Virkamäki, Antti ^a   Malmström, Raija ^a   Utriainen, Tapio ^a   Yki Jarvinen, Hannele ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADULT; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FOREARM; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; KINETICS; MALE;

EID: 0030021925     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.707     Document Type: Article

References (40)

1. Baron AD, Laakso M, Brechtel G, Edelman SV. 1991 Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 73:637-643.
2. Bennet WM, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ. 1990 Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol. 259:E185-E194.
3. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL. 1991 Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest. 87:2246-2252.
4. Bonadonna RC, Saccomani MP, Seely L, et al. 1993 Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes. 42:181-198.
5. Vollenweider P, Tappy L, Randin D, et al. 1993 Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 92:147-154.
6. Jackson RA, Peters N, Advani U, et al. 1973 Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes. 22:442-458.
7. Yki-Järvinen H, Young AA, Lamkin C, Foley JE. 1987 Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest. 79:1713-1719.
8. Kelley D, Mitrakou A, Marsh H, et al. 1988 Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest. 81:1563-1571.
9. Bonadonna RC, Del Prato S, Saccomani MP, et al. 1993 Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest. 92:486-494.
10. Natali A, Buzzigoli G, Taddei S, et al. 1990 Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes. 39:490-500.
11. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA. 1990 Localization of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes. 39:157-167.
12. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. 1995 Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 38:555-564.
13. Laakso M, Edelman SV, Brechtel G, Baron AD. 1990 Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest. 85:1844-1882.
14. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. 1993 Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. 21:129-135.
15. DeFronzo RA, Simonson D, Ferrannini E. 1982 Hepatic and peripheral insulin resistance: a common feature of type II (non-insulin-dependent) and type I (insulin-dependent) diabetes mellitus. Diabetologia. 23:313-319.
16. Yki-Järvinen H, Koivisto VA. 1986 Natural course of insulin resistance in type I diabetes. N Engl J Med. 315:224-230.
17. Yki-Järvinen H. 1992 Glucose toxicity. Endocr Rev. 13:415-431.
18. Elliot TG, Cockcroft JR, Groop P-H, Viberti GC, Ritter JM. 1993 Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci. 85:687-693.
19. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. 1993 Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet. 342:883-887.
20. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
21. Rabinowitz D, Zierler KL. 1962 Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest. 41:2173-2181.
22. Rising R, Swinburn B, Larson K, Ravussin E. 1991 Body composition in Pima Indians: validation of bioelectrical resistance. Am J Clin Nutr. 53:594-598.
23. Kadish AH, Little RL, Sternberg JC. 1968 A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 14:116-131.
24. Desbuquois B, Aurbach GD. 1971 Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab. 33:732-738.
25. Cole RA, Soeldner JS, Dunn PJ, Bunn HF. 1978 A rapid method for the determination of glycosylated hemoglobins using high-performance liquid chromatography. Metabolism. 27:289-301.
26. DeFronzo RA, Soman V, Sherwin R, Hendler R, Felig P. 1978 Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J Clin Invest. 62:204-213.
27. DelPrato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. 1994 Effect of sustained physiologic hyperinsulinemia and hyperglycemia on insulin secretion and insulin sensitivity in man. Diabetologia. 37:1025-1035.
28. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H. 1992 Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes. 41:571-580.
29. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron A. 1994 Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 94:1172-1179.
30. Jorgensen RG, Russo L, Mattlioli L, Moore WV. 1988 Early detection of vascular dysfunction in type I diabetes. Diabetes. 37:292-296.
31. Kastrup J, Norgaard T, Parving H-H, Lassen NA. 1987 Decreased distensibility of resistance vessels of the skin in type I (insulin-dependent) diabetic patients with microangiopathy. Clin Sci. 72:123-130.
32. Hauer JL, Boland OM, Ewing DJ, Clarke BF. 1991 Hand skin blood flow in diabetic patients with autonomic neuropathy and microangiopathy. Diabetes. 14:897-902.
33. Steel M, Nolan A, Nankervis A, et al. 1993 Forearm arterial vascular responsiveness in insulin-dependent diabetic subjects. Diabetes Res Clin Pract. 21: 127-136.
34. Gilmore JE, Allen JA, Hayes JR. 1990 A comparison of peripheral vasoconstrictor responses and cardiovascular autonomic function tests in diabetic patients. Diabetologia. 33:350-356.
35. 133 and vascular calcifications in diabetics. Acta Med Scand. 183:449-454.
36. Chen M, Whistler RL. 1977 Metabolism of D-fructose. Adv Carbohydr Chem Biochem. 34:285-343.
37. Yki-Järvinen H, Bogardus C, Howard BV. 1987 Hyperglycemia stimulates carbohydrate oxidation in man. Am J Physiol. 253:E376-E382.
38. Marshall S, Bacote V, Traxinger RR. 1991 Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 266:4706-4712.
39. Rossetti L, Hawkins M, Gindi J, Barzilai N. 1995 In vivo glucosamine infusion induces insulin resistance in normoglycemic but not hyperglycemic conscious rats. J Clin Invest. 96:132-140.
40. Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimattila S, DeFronzo RA. 1995 Glutamine: fructose-6-phosphate amidotransferase (GFA) activity in skeletal muscle of patients with IDDM and NIDDM. Diabetes. 44:16A.